Stock EPRX EUPRAXIA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Eupraxia Pharmaceuticals Inc.

Equities

EPRX

CA29842P1053

Delayed Toronto S.E.
Other stock markets
 12:37:01 2024-05-21 pm EDT 		5-day change 1st Jan Change
3.95 CAD -1.25% Intraday chart for Eupraxia Pharmaceuticals Inc. -1.50% -26.44%
May. 14 Eupraxia Pharmaceuticals Inc. Brief: Says To Present Initial Results from Ongoing Phase 1b Study of EP-104GI for Treatment of Eosinophilic Esophagitis at Upcoming Digestive Disease Week Annual Meeting 2024 MT
May. 08 Eupraxia Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Chart calendar Eupraxia Pharmaceuticals Inc.

8f16200d714c5.TBQpii1ze2Mg_Z48OaI-55-aJXl7O_V9Baoph0XrJ88.HS1duGJASTJqzOhmTNZm0dPDbkw6V7gbT5kftimqa6Qfcx6zeUYhJm6z2w~a57ac006f990271900e4f86c8dcd3dbe

Upcoming events on Eupraxia Pharmaceuticals Inc.

2024-06-06 01:00 pm Annual General Meeting
2024-08-08 Q2 2024 Earnings Release (Projected)
2024-11-04 Q3 2024 Earnings Release (Projected)
2025-03-31 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)

Past events on Eupraxia Pharmaceuticals Inc.

2024-05-18 12:30 pm Digestive Disease Week Conference - Abstract No - 4031521
2024-05-08 05:02 pm Q1 2024 Earnings Release
2024-04-20 08:40 am Osteoarthritis Research Society International World Congress - Abstract No:063
2024-04-19 10:15 am Osteoarthritis Research Society International World Conference - Abstract No 4031577
2024-04-19 10:15 am Osteoarthritis Research Society International World Congress - Poster No: 418
2024-04-16 10:30 am Bloom Burton & Co. Healthcare Investor Conference
2024-04-01 05:01 pm Q4 2023 Earnings Release
2023-11-14 05:01 pm Q3 2023 Earnings Release
2023-11-14 09:00 am American College of Rheumatology Conference - Poster Number: L04
2023-09-11 12:00 am H.C. Wainwright Global Investment Conference
2023-09-08 10:30 am PAINWeek national conference
2023-08-11 05:00 pm Q2 2023 Earnings Release
2023-06-26 11:00 am EP-104IAR Phase 2b Clinical Trail Results Call
2023-05-30 01:00 pm Annual General Meeting
2023-05-11 07:00 am Q1 2023 Earnings Release
2023-04-25 10:30 am Bloom Burton & Co Healthcare Investor Conference
2023-03-23 05:00 pm Q4 2022 Earnings Release
2022-11-07 07:00 am Q3 2022 Earnings Release
2022-09-12 07:00 am H.C. Wainwright Global Investment Conference
2022-08-12 07:00 am Interim 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CAD		Released
Forecast
Spread 		0,00


0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million CAD		Released
Forecast
Spread 		0,00


0,00


0,00
0,00
- 		-23,1
-14,0
-64.72%		-27,7
-30,0
7.69%
-30,0

EBIT
Million CAD		Released
Forecast
Spread 		0,00


0,00


0,00
0,00
- 		-23,2
-23,4
0.63%		0,00
0,00
-
-37,0

Earnings before Tax (EBT)
Released
Forecast
Spread 		0,00


0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

Net income
Million CAD		Released
Forecast
Spread 		-7,18


-4,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EPS
CAD		Released
Forecast
Spread 		-0,29


-0,65


-1,85
-1,80
-2.78%		0,00
0,00
- 		0,00
0,00
-
0,00

Announcement Date10/02/2130/03/2129/03/2223/03/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million CAD		Released
Forecast
Spread


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00

EBIT
Million CAD		Released
Forecast
Spread








-8,80
-8,95
1.65%		-4,79
-7,80
38.65%		-7,65
-8,00
4.38%		-8,88
-8,15
-9.01%


-6,69
-8,91
24.87%
-8,50


-8,50


-13,4

Net income
Million CAD		Released
Forecast
Spread 		-3,69



































EPS
CAD		Released
Forecast
Spread 		-0,26



































Announcement Date05/05/2212/08/2207/11/2223/03/2311/05/2311/08/2314/11/2301/04/2408/05/24---

Upcoming sector events for Eupraxia Pharmaceuticals Inc.

2024-05-21 CUREVAC N.V.: Q1 2024 Earnings Release (Projected)
2024-05-21 EVOTEC SE: Q1 2024 Earnings Release
2024-06-30 IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected)
2024-07-15 01:45 am ADDLIFE AB: Q2 2024 Earnings Release
2024-07-21 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-23 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-23 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
2024-07-23 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
2024-07-23 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
2024-07-24 LONZA GROUP AG: Q2 2024 Earnings Release
More events

Past sector events for Eupraxia Pharmaceuticals Inc.

Today 07:00 am EXSCIENTIA PLC: Q1 2024 Earnings Release
Today ALVOTECH: Q1 2024 Earnings Release
2024-05-17 02:00 am BIOARCTIC AB: Q1 2024 Earnings Release
2024-05-15 04:05 pm CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 GNI GROUP LTD.: Q1 2024 Earnings Release
2024-05-14 04:05 pm NUVATION BIO INC.: Q1 2024 Earnings Release
2024-05-14 07:30 am ABSCI CORPORATION: Q1 2024 Earnings Release
2024-05-14 01:50 am BELITE BIO, INC: Q1 2024 Earnings Release
2024-05-13 POLARIS GROUP: Q1 2024 Earnings Release
2024-05-13 04:30 pm AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. EPRX Stock
  4. Calendar Eupraxia Pharmaceuticals Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW